Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score N/A
- Piotroski Score 2.00
- Grade N/A
- Symbol (ANPC)
- Company AnPac Bio-Medical Science Co., Ltd.
- Price $4.30
- Changes Percentage (-3.15%)
- Change -$0.14
- Day Low $4.25
- Day High $4.63
- Year High $11.99
AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 05/16/2023
- Fiscal Year End N/A
- Average Stock Price Target $0.00
- High Stock Price Target $0.00
- Low Stock Price Target $0.00
- Potential Upside/Downside N/A
- Consensus Rating Neutral
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$11.45
- Trailing P/E Ratio -0.37554585152838
- Forward P/E Ratio -0.37554585152838
- P/E Growth -0.37554585152838
- Net Income $-103,598,000
Income Statement
Quarterly
Annual
Latest News of ANPC
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
ANGLE PLC (ANPCY) (Q2 2024) Earnings Call Transcript Highlights: Key Takeaways from the ...
The company has reached its 100th peer-reviewed publication highlighting the clinical potential of Parsortix. Earnings call discussions include details on deals with AstraZeneca, Recursion pilot study...
By Yahoo! Finance | 2 days ago